The World's Greatest Investing Community
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This stock spam was originally sent to TMFPhila:
TapImmune Inc.
Syimbol: TPIV
Currrent Value: $0.47
Shorrt Term Tarrget: $1.25
Lonng Term Tarrget: $4.30
TapImmune Inc. is a biotechnology company specializing in the development of innovative cell based immunotherapeutics and vaccines in the areas of cancer and infectious disease.
The Company's lead product candidate, the AdhTAP vaccine enhancer is designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system.
The Company is also developing a TAP based prophylactic vaccine which initial tests indicate may increase the efficacy of targeted prophylactic vaccines by up to 1000 times.
All eyes are going to be on this Winner with a Major Awareness campaign shifting into top gear.
Keep it on your radar!